Nuvo Reseach NRI.to FDA decision Pliaglis

FDA decision on Pliaglis are reporter today because they don't have any information on the product. It's not a bad news same if the stock price have down today. This news just want say that the answer of the FDA will be reported. Nuvo research should,against me, give the reason on their web site because the investor don't no what will be appened. As soon as the FDA will receive all the information, FDA will give the decision if Pliaglis will be approuved. More detail to come.

NRI.to FDA decision

Against all odds, yesterday was the date that many of us expected, the date that the FDA makes are Pliaglis verdict on the product. The company Nuvo Researchannounced that the datede césision was April 16, 2012 but no news came out.Does he need fear nothing appeared in the news, I think not. I think the decision will be revealed shortly. The company has no interest in hiding the FDA decision.However, this can be frustrating is that the company announced that the date wasApril 16 and several people looked impacience decision. The company could haveéemttre a statement saying the decision would be made soon instead of waiting for people who awaited the decision.

NRI.to - TO WATCH

Monday, we will know the FDA's decision regarding the marketing of Piaglis the United States. This decision should affect the stock price that has stabilized at a price of $ 0.13 for some days. The company is well positioned to see its share price rise with the recent news made ​​Thursday by the directions, which shows a large increase in sales due to the problem of pensaid voltaren. Moreover, with a positive decision from the FDA position and future financial results of the first quarter due out around May or June, the company is well positioned to me that one way for hisshare price continue to grow.